Clinical Trial Update: Treatment of Corneal Abrasions With Topical Tetracaine [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update indicates studies are evaluating topical tetracaine for corneal abrasions in Phase 2 and Phase 3. The current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Abrasion

Drugs mentioned

• Tetracaine (Tetracaine)

Snippet

Sponsor: New York Presbyterian Brooklyn Methodist Hospital | Conditions: Corneal Abrasion | Phase 2, Phase 3 | Status: UNKNOWN